WHO ICTRP trial
A comparative study of CGRP neuropeptide levels in patients with endometriosis…
IRCT20220313054264N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20220313054264N1 |
|---|---|
| Public title | A comparative study of CGRP neuropeptide levels in patients with endometriosis pain treated with dienogest |
| Scientific title | A comparative study of CGRP neuropeptide levels in patients with endometriosis pain treated with dienogest |
| Primary sponsor | Iran University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | endometriosis. |
| Interventions | Intervention group: Patients with endometriosis with pain, according to the doctor's diagnosis for drug treatment of pain Dinogen 2 mg per day orally (tablets) (Iran Hormone Company) once a day for 6 months and assess pain and level The… |
| Registration date | Jun 12, 2022 |
| Target size | 10 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: